AROMADOSES CONFORT URINAIRE
Food supplement declared in France, declaration No 2022-11-198, decision dated 4 November 2022
AROMADOSES CONFORT URINAIRE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRE PERRIGO FRANCE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Capsule
- Daily dose
- 2 capsule matin, midi et soir
- Intended populations
- Personnes de plus de 60 ans, Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Insuffisance rénale, Problèmes de foie, Sous anticoagulants, Utilisation prolongée, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Système urinaire
Declaration 238562, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Satureja montana L. | Essence (sommités fleuries) | Distillation | 68 mg |
| Thymus vulgaris L. | Essence (sommités fleuries) | Distillation | 68 mg |
| Rosmarinus officinalis L. | Essence (parties aériennes) | Distillation | 54 mg |
| Juniperus communis L. | Essence (fruit) | Distillation | 50 mg |
Additives
E422
Other ingredients
huile de sésame, Gélatine de poisson, Eau potable
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Demandez conseil à un professionnel de santé avant utilisation, notamment en cas de troubles gastro-oesophagiens. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Ne pas utiliser chez les femmes enceintes ou qui allaitent. Réservé à l'adulte. Ne pas utiliser chez les personnes épileptiques ou en cas d'antécédents de convulsions. A éviter en cas d'allergie connue à l'un des composants.Ne pas utiliser en cas : d'insufissance rénale, de pathologie hépatique ou hormono-dépendante, de calculs biliaires, en cas de prise d'anticoagulants ou d'antiaggrégants plaquettaires. Ne pas utiliser de manière prolongée, 14 jours maximum. Une consommation excessive peut avoir des effets laxatifs. Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Conserver dans un endroit sec et à l'abri de la chaleur.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thymus vulgaris L.
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Rosmarinus officinalis L.
Read the warning, when it applies and the studies cited
ROSEMARY – ROSMARINUS OFFICINALIS Oral
Route of administration: Oral (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 May 2026
ROSEMARY - ROSMARINUS OFFICINALIS Topical
Route of administration: Topical (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Juniperus communis L.
Read the warning, when it applies and the studies cited
Juniper - Juniperus Communis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.